Biotech Values

[DewDiligence]

ENTA’s CFO exercised and held $3M worth of stock from 77.5K options that did not expire until Jul and Dec 2014; (he also exercised and held $600K of stock from options that were expiring imminently):

http://www.sec.gov/Archives/edgar/data/1177648/000090866214000115/xslF345X03/edgar.xml

In doing this, ENTA’s CFO has added to the $12M of exercise-and hold transactions by the CEO (#msg-95887112) and CSO (#msg-95888322) in Jan 2014. Based on those prior exercise-and-hold transactions, I increased my ENTA stake by 20% in January (#msg-95923408), and the bullish signal turned out well insofar as the share price is up sharply since then.

Meanwhile, CEO Jay Luly still has a 10b5-1 selling plan and he sold 10K shares today via that plan (http://www.sec.gov/Archives/edgar/data/1177648/000090866214000114/xslF345X03/edgar.xml ).